Serological and molecular study of hepatitis E virus among illegal blood donors

Table 1 Prevalence of hepatitis E virus IgG seropositivity in 546 commercial blood donors

	HEV positive IgG n (%)	OR (95% CI)	P value
Sex
Female	76/390 (19.5)	-	0.004
Male	48 /156 (30.8)	1.84 (1.20, 2.80)
Donation frequency
< 10	47/252 (18.7)	-
10-20	44/191 (23.0)	1.31 (0.82, 2.07)	0.258
≥ 20	33/103 (32.0)	2.06 (1.22, 3.46)	0.006
Age (yr)
< 40	7/54 (13.0)	-
40-50	37/192 (19.3)	1.50 (0.63, 3.60)	0.361
50-60	46/189 (24.3)	2.02 (0.85, 4.80)	0.105
≥ 60	34/111 (30.6)	2.78 (1.14, 6.79)	0.022

HEV: Hepatitis E virus; OR: Odd ratio; CI: Confidence interval.

Table 2 Sex specific prevalence of hepatitis E virus IgG seropositivity in commercial blood donors with different frequency of donation n (%)

Frequency	Hepatitis E virus positive IgG		P value
	Male	Female
< 10	15/54 (27.8)	32/198 (16.2)	0.052
10-20	18/57 (31.5)	28/137 (20.4)	0.097
≥ 20	15/45 (33.3)	16/55 (29.1)	0.648

Table 3 Relationship between hepatitis E virus infection and hepatitis B virus or hepatitis C virus co-infection in commercial blood donors n (%)

Characteristics	HEV positive IgG (n = 124)	HEV negative IgG (n = 422)	P value
HBsAg positive	4 (3.2)	13 (3.1)	0.935
HCV antibody positive	14 (11.3)	47 (11.1)	0.962

HEV: Hepatitis E virus.